Epstein Secrets

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

on, according to casae records. In connection with the assignment, Pinto-Thomaz received material, nonpublic or "inside" information the deal about Sherwin-Williams's planned acquisition of Valspar prior to the public announcement of the acquisition. EFTA00069916 S&P's written policies prohibited the unauthorize

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National In

on, according to casae records. In connection with the assignment, Pinto-Thomaz received material, nonpublic or "inside" information the deal about Sherwin-Williams's planned acquisition of Valspar prior to the public announcement of the acquisition. S&P's written policies prohibited the unauthorized disclosure of

he Office of Congressional Ethics reported that it found "a substantial reason to believe" that Collins violated federal law by touting the stock of Innate Immunotherapeutics, an Australian biotech firm, based on inside information. EFTA00085695 The office also said Collins may have broken House ethics rules by persuad

on, according to casae records. In connection with the assignment, Pinto-Thomaz received material, nonpublic or "inside" information the deal about Sherwin-Williams's planned acquisition of Valspar prior to the public announcement of the acquisition. S&P's written policies prohibited the unauthorized disclosure of